Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yonghao Yang

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Immunotherapy|May 16, 2019
Efficacy and safety of nivolumab plus apatinib in advanced liver carcinosarcoma: a case reportLingdi Zhao, Yonghao Yang, Quanli Gao
Immunotherapy|June 28, 2017
Combination of sorafenib and cytokine-induced killer cells in metastatic renal cell carcinoma: a potential regimenYonghao Yang, Hongwei Lin, Lingdi Zhao, et al.
Immunotherapy|August 29, 2018
Nivolumab-induced cytokine-release syndrome in relapsed/refractory Hodgkin's lymphoma: a case report and literature reviewLingdi Zhao, Yonghao Yang, Wei Li, et al.
Accident; Analysis and Prevention|February 18, 2025
A deep transfer learning approach for Real-Time traffic conflict prediction with trajectory dataQinzhong Hou, Yonghao Yang, Jiatong Liang, et al.
Materials (Basel, Switzerland)|April 25, 2019
Use of Basalt Fiber-Reinforced Tailings for Improving the Stability of Tailings DamBinbin Zheng, Dongming Zhang, Weisha Liu, et al.
Environmental Science and Pollution Research International|January 4, 2021
Experimental study on static and dynamic mechanical properties of phosphogypsumTing Lu, Wensong Wang, Zuoan Wei, et al.
Nanoscale|January 8, 2024
Recent progress in the synthesis and applications of covalent organic framework-based compositesMingxuan Ma, Yonghao Yang, Zhonghua Huang, et al.
Frontiers in Oncology|May 7, 2020
Chemotherapy Reverses Anti-PD-1 Resistance in One Patient With Advanced Non-small Lung Cell CancerLingdi Zhao, Baozhen Ma, Yonghao Yang, et al.
Immunotherapy|September 22, 2018
Rapid complete remission of metastatic melanoma after first-line treatment with nivolumab plus tumor-infiltrating lymphocytesLingdi Zhao, Yonghao Yang, Wei Li, et al.
Frontiers in Immunology|November 12, 2021
Axitinib Reverses Resistance to Anti-Programmed Cell Death-1 Therapy in a Patient With Renal Cell CarcinomaYonghao Yang, Hao Huang, Tiepeng Li, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Immunotherapy|May 16, 2019
Efficacy and safety of nivolumab plus apatinib in advanced liver carcinosarcoma: a case reportLingdi Zhao, Yonghao Yang, Quanli Gao
Immunotherapy|June 28, 2017
Combination of sorafenib and cytokine-induced killer cells in metastatic renal cell carcinoma: a potential regimenYonghao Yang, Hongwei Lin, Lingdi Zhao, et al.
Immunotherapy|August 29, 2018
Nivolumab-induced cytokine-release syndrome in relapsed/refractory Hodgkin's lymphoma: a case report and literature reviewLingdi Zhao, Yonghao Yang, Wei Li, et al.
Accident; Analysis and Prevention|February 18, 2025
A deep transfer learning approach for Real-Time traffic conflict prediction with trajectory dataQinzhong Hou, Yonghao Yang, Jiatong Liang, et al.
Materials (Basel, Switzerland)|April 25, 2019
Use of Basalt Fiber-Reinforced Tailings for Improving the Stability of Tailings DamBinbin Zheng, Dongming Zhang, Weisha Liu, et al.
Environmental Science and Pollution Research International|January 4, 2021
Experimental study on static and dynamic mechanical properties of phosphogypsumTing Lu, Wensong Wang, Zuoan Wei, et al.
Nanoscale|January 8, 2024
Recent progress in the synthesis and applications of covalent organic framework-based compositesMingxuan Ma, Yonghao Yang, Zhonghua Huang, et al.
Frontiers in Oncology|May 7, 2020
Chemotherapy Reverses Anti-PD-1 Resistance in One Patient With Advanced Non-small Lung Cell CancerLingdi Zhao, Baozhen Ma, Yonghao Yang, et al.
Immunotherapy|September 22, 2018
Rapid complete remission of metastatic melanoma after first-line treatment with nivolumab plus tumor-infiltrating lymphocytesLingdi Zhao, Yonghao Yang, Wei Li, et al.
Frontiers in Immunology|November 12, 2021
Axitinib Reverses Resistance to Anti-Programmed Cell Death-1 Therapy in a Patient With Renal Cell CarcinomaYonghao Yang, Hao Huang, Tiepeng Li, et al.
Pageof 5